ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy.

Mark J Alberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.